There are a few universal laws in publishing. Gravity makes deadlines fall faster than you can catch them.
Headlines always look smarter at 2:00 a.m. than they do at 8:00 a.m. And if you staple the word
“ancient” to a health claim, someone, somewhere, will try to sell it to your aunt on Facebook.

But every so often, a publication with real scientific gravitas wanders into the wellness aisle, slips on a puddle
of “natural,” and emerges holding a glossy brochure that whispers: “What if Traditional Chinese Medicine is actually the future?”
That’s when readers of evidence-based medicine feel the stocking stuffers transform into… well, a lump of coal.

This article is about that vibe: the uneasy moment when a major science brand appears to lend its halo to
traditional Chinese medicine (TCM)not by publishing rigorous, skeptical coverage, but by flirting with
marketing narratives that TCM promoters have polished for decades. We’ll separate what’s promising from what’s
performative, explain why “personalized” is sometimes code for “hard to test,” and offer a practical toolkit for
readers navigating the collision of publishing, profit, and pseudoscience.

The coal in the stocking: when prestige meets sponsored storytelling

The controversy implied by our title isn’t really about a single herb, a single acupuncture needle, or even a single
editorial decision. It’s about signals. When a prestigious science outlet runs content that reads like an
upbeat sales pitch for “traditional Asian medicine,” critics worry the brand is being used as a credibility laundering machine:
take a contentious medical system, rinse it in glossy graphics and scientific vocabulary, and hang it out to dry as “the next frontier.”

In the case that sparked the “lump of coal” metaphor, critics described a Nature-branded supplement on traditional Asian medicine
that acknowledged financial sponsorship from organizations with a direct stake in the topic. That kind of arrangement can be defensible
only if the editorial process is aggressively independent, transparently labeled, and written with the same skepticism readers expect from
a science publicationespecially when the subject matter already attracts exaggerated claims.

The problem is that sponsored health content often slides into a familiar script:
TCM is ancient, therefore wise; it’s natural, therefore safe; it’s holistic, therefore superior; and it’s personalized, therefore difficult to study.
None of those leaps are scientific. They’re marketing shortcuts dressed as cultural respect.

Why TCM is such a marketing dream (and why that’s not the same as “true”)

1) The “ancient therefore effective” charm spell

TCM is frequently framed as “thousands of years of observation.” That sounds impressive until you remember:
lots of things lasted thousands of yearslike bloodletting, blaming illness on bad air, and thinking tomatoes were poisonous.
Longevity can mean “useful,” but it can also mean “sticky.”

In evidence-based medicine, a therapy doesn’t get a free pass because it’s old. It earns a place by demonstrating:
(1) plausible mechanisms, (2) consistent clinical benefits in controlled trials, and (3) acceptable safety and quality control.
Tradition can be a starting hypothesis. It is not a conclusion.

2) The “natural therefore safe” assumption (nature is also where bears live)

“Natural” is the word that sells. Unfortunately, it’s also the word that distracts.
Hemlock is natural. Poison ivy is natural. So are bacteria with aggressive opinions about your intestinal lining.
The safety of any remedyplant, pill, or potiondepends on its chemistry, dose, contaminants, and interactions,
not on whether it was harvested from a mountainside or synthesized in a lab.

3) The “personalized therefore untestable” escape hatch

One of the most common defenses of traditional Chinese herbal formulas is that they’re individualized.
The implication is: “Randomized controlled trials (RCTs) can’t handle this.” But modern medicine tests individualized approaches all the time.
If a treatment is truly personalized, you can still study itby standardizing decision rules, measuring outcomes,
and comparing against credible controls.

“Hard to test” should never be treated as “therefore it works.” If anything, it should trigger the opposite reaction:
show the evidence, because the claims are more vulnerable to bias.

What the science says: separating the useful from the “vibes-based medicine”

Here’s the fairest way to talk about TCM: it’s not one thing. It’s a label covering a wide range of practicessome low-risk,
some potentially helpful, some biologically implausible, and some outright dangerous if poorly regulated.
Treating “TCM” as a single monolith is how you end up either worshipping it or dismissing everything under the umbrella.
Neither is smart.

Mind-body practices: tai chi, movement, and the parts that behave like rehab

Some approaches associated with TCMespecially movement-based practices like tai chioften look less like mystical energy work and more
like gentle, structured exercise paired with breath control and body awareness. Those ingredients can plausibly support balance, mobility,
stress reduction, and quality of life. The benefits may come from biomechanics and nervous-system modulation rather than “qi” traveling through invisible highways.

That matters, because it changes how we evaluate the claims: if the benefit is largely from movement and adherence,
you don’t need metaphysical explanations. You need good studies and honest messaging.

Acupuncture: evidence, controversy, and the “sham needle” problem

Acupuncture is the most studied TCM-associated practice in Western medical literature, and the findings are often “some benefit, modest size, messy interpretation.”
Large analyses have found acupuncture can outperform usual care and can also outperform “sham” procedures by a smaller marginsuggesting
a blend of specific effects, placebo/context effects, and the powerful influence of expectation.

In plain American English: acupuncture may help some people with certain pain conditions, but the mechanism is debated,
and the marketing often runs way ahead of what the data can carry. If you see claims that acupuncture “boosts immunity,”
“detoxes organs,” or “treats cancer,” treat those like a suspicious email asking for your password.

Herbal products: where real pharmacology exists… and where quality control ruins everything

Herbal medicine is where the conversation gets both more interesting and more dangerous. Interesting, because plants can contain potent compounds
that become modern drugs (or inspire them). Dangerous, because real pharmacology cuts both ways: potency without standardization is a recipe for unpredictable outcomes.

Studies of Chinese herbal products show mixed results across conditions. “Mixed” doesn’t mean “worthless.”
It means: some formulas may contain something clinically useful, but results vary, trials differ in quality, and formulations aren’t always consistent.
It’s also hard to generalize: one tested product is not a permission slip for every untested look-alike sold online.

The most scientifically productive stance is neither “TCM is magic” nor “TCM is trash,” but:
test specific products, identify active ingredients, standardize dosing, monitor safety, replicate results.
That’s how medicine works when it’s not cosplaying as mythology.

Safety: the part marketers whisper about (and regulators lose sleep over)

In the U.S., dietary supplements and herbal products occupy an awkward regulatory space:
they’re often marketed like medicines, but regulated more like foods. That gap creates fertile ground for contaminated products,
adulteration, and exaggerated claimsespecially when consumers assume “herbal” equals “gentle.”

Aristolochic acid: a cautionary tale written in kidney tissue

Aristolochic acid is a naturally occurring compound found in certain plants used in some traditional remedies.
It has been linked to severe kidney damage and cancers of the urinary tract. This is not a “maybe.”
It’s a real example of how “natural” can be profoundly harmfulparticularly when products are misidentified, mislabeled, or sold without adequate safeguards.

Ephedra: when “energy” turns into emergency

Ephedra (and ephedrine alkaloids) became notorious in the U.S. supplement market for being associated with serious adverse events.
The public health story is blunt: stimulant-like effects plus aggressive marketing equals a predictable spike in harm.
It’s a reminder that herbs can act like drugsbecause, chemically, that’s exactly what they are.

Contamination and adulteration: the invisible ingredient list

U.S. health agencies and academic medical centers repeatedly warn that some herbal products may contain heavy metals, pesticides,
microorganisms, or even undisclosed pharmaceuticals. Manufacturing errors can swap one plant for another. Online marketplaces can
amplify the problem because “third-party seller” sometimes means “third-party mystery chemistry.”

And then there are interactions: herbal supplements can alter how prescription medications work.
Blood thinners, heart medicines, antidepressants, and chemotherapy agents are not the places to improvise.
If your “natural regimen” has never been reviewed by a clinician or pharmacist, you’re basically running a home chemistry labwithout the goggles.

Publishing ethics: when a science brand rents out its credibility

Let’s talk about the real scandal behind the Christmas coal: not that TCM exists, but that editorial packaging can blur
the line between reporting and promotion. Sponsored sections, advertorials, and “special supplements” can be done responsiblybut they can also
become credibility shortcuts for industries that want the aesthetics of science without the inconvenience of skepticism.

Even when a publication claims editorial control, sponsorship creates pressuresubtle or directto frame a topic favorably,
pick friendlier experts, and emphasize “future potential” over present uncertainty. And when a topic is already controversial,
a glossy tone can function as a persuasive tool whether or not it was intended that way.

This isn’t theoretical. High-profile episodes in science publishing have shown how sponsorship and editorial processes can collide,
sometimes even leading to retractions or policy reviews when authors and readers feel misled about funding relationships.

The cost is trust. Once readers suspect a scientific outlet is polishing a sponsor’s message, every headline starts sounding like an infomercial:
“But waitthere’s more qi!”

A reader’s skepticism toolkit: how to evaluate TCM claims without becoming a cynic

Ask “What exactly is being claimed?”

“TCM works” is too vague to be meaningful. Which practice? For which condition? Compared against what? In what population?
Vagueness is the favorite camouflage of weak claims.

Look for outcomes that matter (not just lab graphs)

A chart showing a biomarker moving is not the same as a patient living longer, functioning better, or suffering less.
Useful medicine improves real outcomes in real humans, ideally in multiple trials.

Be allergic to the word “detox”

Your liver and kidneys detox you continuously, for free, without a subscription plan.
If someone promises “detox,” ask for a specific toxin, a measurable endpoint, and clinical evidence.
If the answers are vibes and metaphors, you’re not in medicine anymoreyou’re in poetry.

Check safety, quality, and interactions like your future self depends on it

If you’re considering Chinese herbal products, prioritize reputable sourcing, third-party testing where available,
and a clinician reviewespecially if you’re pregnant, older, managing chronic illness, or taking prescriptions.
The goal is not to “avoid herbs.” The goal is to avoid preventable harm.

The bigger picture: “East vs West” is a story, not a standard of evidence

One of the most persistent tropes in pro-TCM coverage is the false dichotomy:
the “West” is cold and reductionist; the “East” is warm and holistic. It’s a narrative designed to make skepticism feel like cultural disrespect.
But evidence doesn’t have a passport. If a therapy works, it works anywhereunder transparent testing.

Respecting a culture’s history does not require accepting every medical claim attached to it. Real respect means taking people’s health seriously enough
to demand proof, protect safety, and resist exploitationespecially when marketing uses tradition as a shield against accountability.

Conclusion: don’t put coal in the lab coat pocket

Traditional Chinese medicine sits at a complicated intersection: cultural heritage, genuine pharmacology, modern consumer wellness, and political branding.
Some associated practices may support well-being. Some herbs may contain useful compounds. Some clinical trials are worth following.
But the leap from “some promising elements” to “TCM is the cutting edge” is exactly where shilling begins.

When prestigious science outlets publish content that leans promotionalespecially in sponsored contextsthey risk turning scientific authority into a holiday prop:
shiny on the outside, disappointingly heavy in the stocking. Readers don’t need a purity test. They need clarity:
what’s evidence-based, what’s uncertain, what’s unsafe, and what’s marketing dressed up as medicine.

If science publishing wants to avoid handing out coal, it has one job: keep skepticism in the foreground, even when sponsors would prefer a soft-focus glow.
Because credibility is hard to earn, easy to rent, and painfully expensive to buy back.

Experiences from the real world: how “TCM shilling” actually feels up close

If you want to understand why “shilling for traditional Chinese medicine” makes scientifically minded readers grind their teeth,
don’t start with a debate about meridians. Start with the lived experience of trying to make responsible decisions in a marketplace
that rewards confidence over caution.

Experience #1: The waiting room recommendation. Someone you trustmaybe a family member, maybe a coworker who swears they “never get sick”leans in and says,
“You should try this Chinese herbal formula. It’s been used forever.” The pitch is affectionate, not sinister. And that’s the point:
most misinformation isn’t delivered by villains in capes. It arrives wrapped in good intentions and a link to an online shop with a five-star rating system that
measures enthusiasm, not evidence. You’re suddenly the person who has to say, “I’m glad it helped you, but what’s in it, and has it been tested?”
Congratulations: you’re now the designated buzzkill.

Experience #2: The glossy authority glow. You’re reading a polished, prestigious-looking featureclean typography, confident tone, scientific words sprinkled like parsley.
It doesn’t scream “advertisement,” but it also doesn’t ask hard questions. Instead, it emphasizes “integration,” “systems biology,” and “personalized medicine,”
like those phrases automatically upgrade a claim from “maybe” to “medicine.” The emotional whiplash is real: you want to trust the brand, but your internal skeptic is
tapping the glass like a goldfish begging for critical appraisal. The frustration isn’t that the article mentions TCMit’s that it seems to sell TCM without earning it.

Experience #3: The label that tells you nothing. You pick up a product marketed as “traditional Chinese medicine.”
The ingredients list is either vague, translated inconsistently, or packed with botanical names that require a minor in Latin and a side quest through MedlinePlus.
Dosage guidance is fuzzy. Contraindications are tiny. Then a friend says, “It’s safeit’s natural.” This is where real-world caution kicks in.
People aren’t irrational for wanting alternatives; they’re rational for wanting relief. But the system makes it hard to be a smart consumer because the information is incomplete,
and sometimes the supply chain is, frankly, a black box.

Experience #4: The medication interaction scare. A clinician asks what you’re taking. You list prescriptions.
Then, almost as an afterthought, you mention an herbal blend. The clinician’s expression changesnot because they’re anti-herb, but because they’re pro-not-bleeding-out.
They explain interactions, liver risks, or the problem of adulteration. You realize something important:
the most dangerous part of supplements isn’t always the supplement. It’s the silence around itpatients not mentioning it, providers not asking,
and marketing that frames disclosure as unnecessary.

Experience #5: The “it helped me” paradox. People do feel better sometimesafter acupuncture, after tai chi, after herbal teas.
Pain fluctuates. Stress drops when someone spends time and attention on you. Ritual can be powerful. That’s not nothing.
The problem is what happens next: personal relief becomes universal claims. A modest benefit becomes “cures the root cause.”
And if a prestigious outlet seems to nod along, the escalation accelerates.

Put all of these experiences together and you get the core issue: readers aren’t angry that TCM is studied or discussed.
They’re angry when scientific credibility is used like a coupon code“Use NATURE at checkout for 20% off skepticism.”
The lived experience is a tug-of-war between hope and rigor. Good science journalism helps you hold both.
Shilling forces you to choose, and it usually chooses for you.

The post Shilling for traditional Chinese medicine: Nature leaves its readers a lump of coal before Christmas appeared first on Everyday Software, Everyday Joy.

Every few months, a well-meaning lawmaker somewhere in the United States wakes up and says,
“We really ought to regulate this alternative medicine stuff.” Task forces are formed,
hearings are held, and suddenly there’s a brand-new bill to license crystal whisperers,
detox foot-bath technicians, and people who sell supplements that promise to “optimize”
anything that sits still long enough.

On the surface, this sounds reassuring. Regulation feels like order. Licenses and official
boards sound like protection. But there’s a problem that science-based clinicians have been
pointing out for years: when you formally regulate nonsense, what you mostly succeed in doing
is blessing nonsense. The public sees something wrapped in legal language and assumes
it has been vetted by science, not just by lobbyists.

In other words, the regulation of nonsense tends to create regulated nonsense. And that is
not what evidence-based healthcare is supposed to look like.

What do we mean by “nonsense” in medicine?

In everyday life, “nonsense” might mean a weird family superstition or your coworker’s
conspiracy theory about printer paper. In medicine, the word is narrower and much more
serious. Here, we’re talking about health interventions that:

• Are not backed by credible, reproducible evidence
• Often contradict well-established principles of biology, chemistry, or physics
• Are marketed using emotional stories instead of solid data
• Sometimes directly conflict with effective, life-saving care

That includes a wide range of practices and products often lumped under the “complementary
and alternative medicine” (CAM) umbrella: homeopathy that dilutes ingredients past the point
where any molecules remain, “energy medicine” that adjusts unmeasurable, undefined fields,
supplements that claim to cure multiple unrelated diseases, and detox regimens that never
quite specify the toxin.

The key point isn’t whether a therapy feels traditional, natural, or comforting. The key
point is whether it works better than placebo and is reasonably safe. When therapies fail
those basic tests, trying to regulate them the same way we regulate genuine medical
interventions creates a tangle of risk, confusion, and unintended consequences.

The strange logic of licensing pseudoscience

One of the central arguments from science-based critics is simple: if you create a licensing
system for a practice that is not grounded in reality, you inevitably end up with rules that
entrench that unreality. You can’t write a law about which herbs “balance energy channels”
without first pretending that such channels exist.

Licensing boards for pseudoscientific professions tend to focus on internal coherence
(“Did you follow the rules of this belief system?”) rather than actual medical outcomes.
A homeopath can be disciplined for using the “wrong remedy” under the doctrine of
homeopathy but not for the fact that high-quality trials consistently fail to show that
homeopathic remedies perform better than placebos.

From the outside, though, the public rarely sees that nuance. They just see:

• A state board
• A license hanging on the wall
• A title that sounds medical-ish

Combine that with white coats, stethoscopes, and a website full of wellness buzzwords, and
it becomes almost impossible for a non-expert to distinguish between science-based medicine
and a regulated system of elaborate placebos.

Why the U.S. regulatory patchwork invites nonsense

To really appreciate how nonsense sneaks into the system, you have to understand that
healthcare in the United States is governed by a patchwork of overlapping rules and
agencies:

• Federal agencies such as the Food and Drug Administration (FDA) and
  Federal Trade Commission (FTC) oversee products, labeling, and advertising claims.
• State governments license professionals and define scopes of practice.
• Legislatures can carve out special exceptions for certain industries
  and traditions.

Decades of lobbying by the supplement and CAM industries have created generous carve-outs
that let many products onto the market with minimal premarket scrutiny. Under the
Dietary Supplement Health and Education Act (DSHEA), for example, most supplements do not
require FDA approval before they are sold, and the burden of proof is often shifted to the
government to act after harm occurs rather than before the product launches.

At the same time, states have created licensure for a range of non-physician practitioners,
sometimes based more on political compromise than on evidence of efficacy. Once those
practice acts are in place, rolling them back is politically painful. No one wants to be
accused of “taking away people’s choices,” even if the choice in question is between
chemotherapy and a smoothie cleanse.

How pseudoscience leverages the language of regulation

Industries that rely on weak evidence have learned to speak fluent regulator-ese. You’ll
see phrases like:

• “Complies with all applicable FDA regulations”
• “Manufactured in an FDA-registered facility”
• “Meets current Good Manufacturing Practices (cGMP)”

None of those statements mean the product has been tested and proven to do what the label
claims. They mostly describe how the product is made and labeled, not whether it
works. A beautifully labeled sugar pill is still a sugar pill.

Even disclaimers can be weaponized. You’ve probably seen the classic supplement disclaimer:
“This statement has not been evaluated by the Food and Drug Administration. This product
is not intended to diagnose, treat, cure, or prevent any disease.” It appears in tiny text
under a giant promise to boost immunity, rejuvenate your brain, or reverse aging.

For science-literate readers, the disclaimer is a warning. For everyone else, it’s just
legal wallpaper behind a glossy lifestyle fantasy.

The FTC, FDA, and the slow battle against health scams

Thankfully, the system is not completely asleep at the wheel. The FTC regularly brings
cases against companies that make blatantly deceptive health claims, from miracle weight
loss pills to devices that promised to prevent COVID-19 with almost no evidence behind
them. The bar, at least in theory, is that health claims must be supported by “competent
and reliable scientific evidence.”

In parallel, the FDA has updated its approach to homeopathic products and certain CAM
therapies, moving away from a hands-off stance toward prioritizing enforcement against
higher-risk productsthose that make serious disease treatment claims, target vulnerable
populations, or contain potentially unsafe ingredients.

But enforcement is resource-intensive, and the marketplace of nonsense is endlessly
inventive. For every product the agencies manage to challenge, dozens more pop up with
slightly tweaked wording, fresh branding, or a different “natural” angle.

Why the current system still falls short

From a science-based medicine perspective, the core problem isn’t that regulators never act.
It’s that the default posture of the law is not “prove it works before you sell it,” but
“sell it until someone proves it’s harmful or misleading.” That asymmetry favors nonsense
by design.

Add in the communication challengeagencies publishing careful, technical guidance while
marketers publish eye-catching TikToksand you have a playing field that is tilted heavily
toward those willing to stretch the truth.

Medical freedom vs. consumer protection: the rhetorical trap

There is a powerful rhetorical move that defenders of pseudoscientific products use over and
over: they frame any attempt to tighten evidence standards as an attack on “health freedom.”
Smart regulation is recast as a tyrannical attempt to control what people put in their own
bodies.

This is emotionally compelling but logically confused. Science-based regulation does not
dictate which choices individuals make. It sets a reasonable floor for honesty:

• If you claim to prevent disease, you should actually be able to prevent disease.
• If you claim to cure a condition, your product should outperform placebo in good trials.
• If you sell something with real risks, those risks should be clearly disclosed.

Requiring evidence is not an assault on freedom; it is a defense of people’s right not to
be misled when they are scared, sick, or desperate. Pseudoscience thrives precisely when
people are most vulnerable and least able to critically evaluate what they’re being sold.

What a science-based regulatory framework would actually look like

If we took science-based medicine seriously as the guiding principle, regulation would look
very different from the current mix of loopholes, special categories, and euphemistic
disclaimers. A more rational framework might include:

1. One evidence standard for all health claims

Whether a product is labeled as a “drug,” “supplement,” “natural remedy,” or “traditional
formula,” the same core rule would apply: if you make a specific health claim, you need
solid evidence to back it up. Not testimonials, not cherry-picked in vitro studies, but
credible clinical data that would satisfy a skeptical, independent expert.

2. Transparency by default

Labels and ads should clearly state what is known and what is not. If evidence is
weak, preliminary, or contradictory, that should be communicated in plain language. If no
clinical trials exist, that should be explicit rather than hidden behind vague phrases like
“traditionally used for.”

3. No special carve-outs for magical thinking

Laws should not codify concepts with no basis in reality, such as “balancing life energy”
or “correcting quantum vibrations” of organs. People are free to believe in those ideas on
their own time, but they shouldn’t be embedded into professional practice acts or used to
shield purveyors from normal evidence requirements.

4. Proactive protection for high-risk situations

Regulators should prioritize interventions that:

• Claim to treat serious diseases (cancer, heart disease, diabetes, neurodegenerative conditions)
• Target children, older adults, or other vulnerable populations
• Encourage people to delay or abandon proven treatments

In those settings, even “low-risk” nonsense is not benign, because the main harm is not the
sugar pill itself; it’s the opportunity cost of lost time and neglected real care.

What individuals can do while the system catches up

While we wait for lawmakers to grow spines and regulatory frameworks to catch up with
reality, individual patients and families still have to navigate the maze. A few practical
filters can help:

• Be suspicious of big promises. If something claims to cure everything
  from arthritis to Alzheimer’s, it probably does none of those things.
• Look for real evidence, not just stories. Stories can be comforting, but
  they are not a substitute for controlled trials.
• Ask who benefits if you believe this. Is someone selling you an expensive
  product or long-term treatment plan?
• Talk to a science-literate clinician. A good doctor, pharmacist, or other
  evidence-based professional should be able to help you weigh risks and benefits honestly.

You don’t need to become an expert epidemiologist to protect yourself. You just need a
healthy skepticism, a willingness to ask hard questions, and an understanding that the
phrase “all-natural” has no magical powers.

Experiences from the front lines of regulating nonsense

The debate over the regulation of nonsense is not just an abstract legal puzzle. It plays
out in clinics, pharmacies, board meetings, and kitchen tables every day. Here are some
composite scenariosdrawn from how these issues typically appear in real lifethat show
what’s at stake.

The oncologist and the “licensed” alternative clinic

Imagine an oncologist meeting a new patient with advanced cancer. The patient has spent the
last year visiting a licensed alternative clinic that offers vitamin infusions, “immune
boosting” injections, and high-priced detox plans. The clinic is state-licensed, the staff
wear white coats, and the waiting room has a wall of framed certificates.

From the patient’s perspective, this looked legitimateafter all, the practitioners had
official titles and regulatory approval. But the treatments, while emotionally comforting,
had no meaningful impact on the cancer. Valuable time was lost, and by the time evidence-based
care begins, the window for cure has narrowed.

The oncologist’s anger is not directed at the patient, but at a system that licensed a set
of practices whose foundational claims were never held to scientific standards. Regulation
in this case did not protect; it camouflaged the problem.

The pharmacist and the supplement aisle

In many large U.S. pharmacies, the supplement aisle looks almost indistinguishable from the
prescription counter. Bottles are color-coordinated, labels are polished, and health claims
hover right on the line between implication and explicit promise.

Pharmacists routinely field questions like, “This says it supports joint healthdoes it
actually work?” or “Is this homeopathic cold medicine okay for my toddler?” The awkward
reality is that many of these products are on the shelves not because they cleared a
rigorous evidence bar, but because they fall into regulatory categories that require far
less proof.

Some pharmacists print out summaries of the evidence, others steer people gently back toward
treatments with proven benefit, and some simply shrug under the weight of time pressure.
The mismatch between how “official” these products look and how little we actually know
about their effectiveness is a daily reminder of how partial our regulation really is.

The regulator trying to prioritize real harm

Regulators themselves are often acutely aware of these limitations. Picture a career staffer
at a federal agency reviewing complaints: there are miracle cancer cures advertised online,
weight loss teas linked to liver injury, and a company selling homeopathic remedies for
infants with vague claims about “supporting respiratory wellness.”

With limited staff and legal constraints, the regulator has to choose where to spend their
enforcement capital. They know that going after one particularly egregious scam may send an
important signal, but they also know that thousands of smaller nonsense claims will persist
unchallenged simply because the law wasn’t written to demand proof before such
products flood the market.

It is frustrating work: trying to use a leaky bucket to bail out a boat that someone
keeps drilling new holes into.

The patient caught between hope and skepticism

Finally, there is the person at the center of all this: the patient. Maybe they’ve just
received a new diagnosis. Maybe conventional treatment helped but didn’t fully resolve
their symptoms. Maybe they feel dismissed or rushed by a healthcare system that is
overstretched and under-empathetic.

Then they encounter a regulated alternative practitioner who spends an hour listening,
nodding, and offering a tidy explanation for every symptom based on energy, toxins,
imbalances, or a handful of lab tests of dubious value. It feels human and attentive in a
way that many mainstream encounters do not.

From this vantage point, the fact that the practitioner is licensed, or the supplement is
sold in a chain pharmacy, seals the deal. Regulation has done what good branding alone
could never do: it has conferred a sense of institutional trust. The patient is not being
foolish; they are responding to cues the system itself created.

This is why science-based medicine argues that the only honest way forward is to align our
regulatory signals with reality. Licensure, shelf placement, and advertising rules should
all point in the same direction: toward interventions that are grounded in good evidence
and away from those that are mostly storytelling wrapped in legal disclaimers.

Conclusion: regulating for reality, not rhetoric

The regulation of nonsense is one of the most quietly consequential issues in modern
healthcare. It shapes what patients see in pharmacies, what they hear in clinics, and how
they interpret the difference between a science-based treatment and a promising story with
no data behind it.

If we license pseudoscience as if it were medicine, the public will, quite reasonably,
treat it as medicine. If we give health products a free pass on evidence as long as they
wear the right marketing language, nonsense will continue to flourish in the gaps between
law and science.

A genuinely science-based regulatory system would be more boring, more demanding, and far
less friendly to magical thinking. It would also be more honest. And when people’s health,
savings, and time are on the line, honesty is the least the system can offer.

The post The regulation of nonsense appeared first on Everyday Software, Everyday Joy.